SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending as investors react to a new advertising partnership with OpenAI, which is being viewed as a significant validation of the company's AI-driven data intelligence capabilities. While the community is actively debating the stock's long-term growth potential and institutional accumulation, sentiment remains divided between those expecting a major breakout and those expressing frustration over recent price volatility and management's stock-based compensation practices.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is seeing significant momentum and bullish sentiment as investors rotate capital from high-flying semiconductor stocks back into enterprise software. Community discussion is heavily focused on the stock's potential for a broader recovery, fueled by positive analyst coverage and high-profile institutional interest.

T1 Energy, Inc. engages in developing battery solutions. It focuses on energy storage systems and commercial mobility. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

T1 Energy is experiencing heightened trading activity driven by the disclosure of a new 10-million-share stake by Situational Awareness and a broader pivot toward the company as a leveraged play on U.S. power grid expansion for AI and data centers. The community is actively debating the company's transition from a niche solar manufacturer to a critical energy infrastructure provider, balancing enthusiasm for potential institutional re-rating against risks from ongoing convertible note dilution and short interest volatility.

Bakkt, Inc. is building the backbone of next-generation financial infrastructure. The company provides solutions that enable institutional participation in the digital asset economy, spanning Bitcoin, tokenization, stablecoin payments, and AI-driven finance. Bakkt was founded in 2018 and is headquartered in New York, NY.

Bakkt Inc. - Ordinary Shares - Class A

Bakkt Holdings Inc

Bakkt Holdings is currently a focal point for investors due to its strategic pivot toward stablecoin infrastructure and upcoming DTR acquisition, which is fueling intense community debate regarding its long-term viability. While bulls point to significant insider activity and the potential for a regulatory-driven turnaround, bears remain highly skeptical, citing historical dilution and persistent earnings shortfalls.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler shares are trending as investors weigh an analyst upgrade to Buy against broader sector volatility, with the community actively debating whether the company represents a re-rating opportunity or a catch-up trade alongside other cybersecurity leaders. While some market participants express frustration over recent price performance and lingering valuation concerns, others highlight Zscaler's durable demand in secure network access and its structural position within the AI infrastructure expansion as key long-term catalysts.

Dominion Energy, Inc. engages in the production and distribution of energy. It operates through following business segments: Dominion Energy Virginia, Dominion Energy South Carolina, Contracted Energy, and Corporate and Other. The Corporate and Other segment focuses on corporate, service company, non-controlling interest in Dominion privatization, and non-regulated retail energy marketing operations. The company was founded by William W. Berry in 1983 and is headquartered in Richmond, VA.

Dominion Energy Inc

Dominion Energy is trending as investors digest the announcement of a massive $67 billion all-stock merger with NextEra Energy, a deal designed to address the surging demand for electricity driven by AI data centers. While the community is actively debating the potential for long-term synergy versus the risk of regulatory hurdles, the stock is seeing significant volatility as traders speculate on the valuation and the future of the company's dividend payout.

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

Biomarin Pharmaceutical Inc. - Registered Shares

Biomarin Pharmaceutical is facing market volatility following mixed results in the Phase 3 ENERGY 3 trial for ENPP1 deficiency, which met one of two co-primary endpoints. The community is actively debating the company's long-term pipeline potential and management's strategic focus, with some investors viewing the current dip as a buying opportunity given the strength of the Voxzogo franchise.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is trending as investors weigh its upcoming earnings report against broader macro pressures, with the community actively debating whether it serves as a defensive value opportunity or faces a deeper downturn due to interest rate sensitivity and consumer fatigue. Discussions are heavily focused on potential volatility around the print, with many participants analyzing the correlation between housing-related stocks, treasury yields, and the Pro customer demand signal.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is experiencing significant volatility as investors debate the impact of new generative AI security tools on enterprise software demand. While some community members view the sell-off as an irrational overreaction to AI-driven hype, others are expressing concern that evolving cyber threats and increased enterprise scrutiny could compress margins for established industry leaders.

GraniteShares ETF Trust - GraniteShares 2x Long NOW Daily ETF

GraniteShares 2x Long NOW Daily ETF

Investors are actively debating the potential for a gamma squeeze in NOWL as they weigh the benefits of its 2x leverage against concerns regarding intraday decay and volatility. Many are treating the current price action as an accumulation opportunity, drawing parallels to previous market recoveries while closely monitoring the stock's role in the enterprise AI software ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BNTX here are the abstracts they submitted 

* “First report of efficacy and safety results from a phase 2 trial evaluating BNT327/PM8002 plus chemotherapy as first-line treatment in unresectable malignant mesothelioma.”  
* “DB-1311/BNT324 (a novel B7H3 ADC) in patients with castrate-resistant prostate cancer (CRPC).”  
* “First-in-human phase I/II trial evaluating BNT142, a first-in-class mRNA encoded, bispecific antibody targeting Claudin 6 (CLDN6) and CD3, in patients with CLDN6-positive advanced solid tumors.”  
* “A global Phase 3 double-blind, randomized trial of BNT327/PM8002 plus chemotherapy compared to atezolizumab plus chemo in patients with first-line extensive-stage small cell lung cancer (ES-SCLC).”

StockTwits for iOS

BioNTech SE - ADR

 here are the abstracts they submitted 

* “First report of efficacy and safety results from a phase 2 trial evaluating BNT327/PM8002 plus chemotherapy as first-line treatment in unresectable malignant mesothelioma.”  
* “DB-1311/BNT324 (a novel B7H3 ADC) in patients with castrate-resistant prostate cancer (CRPC).”  
* “First-in-human phase I/II trial evaluating BNT142, a first-in-class mRNA encoded, bispecific antibody targeting Claudin 6 (CLDN6) and CD3, in patients with CLDN6-positive advanced solid tumors.”  
* “A global Phase 3 double-blind, randomized trial of BNT327/PM8002 plus chemotherapy compared to atezolizumab plus chemo in patients with first-line extensive-stage small cell lung cancer (ES-SCLC).”